Members Archive | ERS Genomics

Latest news

Here are the 5 key facts you need to know, so you can secure the licenses that will protect your product and your company.

21 February 2023

21 February 2023

Five things you need to know about using CRISPR/Cas9 commercially

15 February 2023

Welcome to the CRISPR Powerhouse - the power & flexibility of CRISPR/Cas9 for the antibody manufacturing pipeline.

5 January 2023

Foundational CRISPR/Cas9 gene editing patent granted to CVC in Canada

8 December 2022

Crown Bioscience & ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents

1 December 2022

New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio

18 November 2022

New CRISPR/Cas9 Agreement for ERS Genomics and ATLATL

17 November 2022

Gene editing Webinar: Navigating IP, deal-making and regulatory challenges

26 July 2022

ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement

28 June 2022

New CRISPR/Cas9 license agreement for ERS Genomics and Cytosurge

13 June 2022

Advances for India as foundational CRISPR/Cas9 gene editing patent granted